Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα(437 views) Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
Krammer, P.H., Galle, P.R., Moller, P., Debatin, K.M., (1998) Advances in Cancer Research, 65, pp. 251-272. , Vande Woude GF and Klein, G. (eds). Academic Press, Inc.: San Diego
Laemmli, U.K., (1970) Nature, 227, pp. 680-685
Larocca, L.M., Ranelletti, F.O., Maggiano, N., Rutella, S., La Barbera, E.O., Rumi, C., Serra, F., Leone, G., (1997) Int. J. Cancer, 73, pp. 75-83
Le Good, J., Ziegler, W., Parekh, D., Alessi, D., Cohen, P., Parker, P., (1998) Science, 281, pp. 2042-2045
Le Marchand, L., Murphy, S., Hankin, J., Wilkens, L., Ln, K., (2000) J. Natl. Cancer Inst., 92, pp. 154-160
Li, W., Zhang, J., Flechner, L., Hyun, T., Yam, A., Franke, T.F., Pierce, J.H., (1999) Oncogene, 18, pp. 6564-6572
Lowe, S., Lin, A., (2000) Carcinogenesis, 21, pp. 485-495
Mahmoud, N., Carothers, A., Grunberger, D., Bilinski, R., Churchill, M., Martucci, C., Newmark, H., Bertagnolli, M., (2000) Carcinogenesis, 21, pp. 921-927
Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., Umansky, F., Brodie, C., (2001) Cancer Res., 61, pp. 4612-4619
Middleton, E.J., Kandaswami, C., (1993) The Flavonoid: Advance Research Since 1986, pp. 619-652. , Hairbone JH and Liss AR (eds): New York
Mizuno, K., Noda, K., Araki, T., Imaoka, T., Kobayashi, Y., Akita, Y., Shimonoka, M., Ohno, S., (1997) Eur. J. Biochem., 250, pp. 7-18
Morikawa, S., Tatsumi, E., Baba, M., Harada, T., Yasuhira, K., (1978) Int. J. Cancer, 21, pp. 166-170
Mouria, M., Gukovskaya, A.S., Jung, Y., Buechler, P., Hines, O.J., Reber, H., Pandol, S.J., (2002) Int. J. Cancer, 98, pp. 761-769
Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Dixit, V.M., (1996) Cell, 85, pp. 817-827
Nagata, S., (1997) Cell, 88, pp. 355-365
Noroozi, M., Burns, J., Crozier, A., Kelly, I.E., Lean, M.E., (2000) Eur. J. Clin. Nutr., 54, pp. 143-149
Parekh, D., Ziegler, W., Parker, P., (2000) EMBO J., 19, pp. 496-503
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., Hess, R.D., (1996) Oncogene, 13, pp. 1605-1614
Ranelletti, F., Maggiano, N., Serra, F., Ricci, R., Larocca, L., Lanza, P., Scambia, G., Piantelli, M., (2000) Int. J. Cancer, 85, pp. 438-445
Reddy, B.S., (2000) Cancer Epidemiol. Biomarkers Prev., 9, pp. 239-247
Rong, Y., Yang, E.B., Zhang, K., Mack, P., (2000) Anticancer Res., 20, pp. 4339-4345
Ruiz-Ruiz, M.C., Robledo, G., Font, J., Izquierdo, M., Lopez-Rivas, A., (1999) J. Immunol., 163, pp. 4737-4746
Russo, M., Palumbo, R., Tedesco, I., Mazzarella, G., Russo, P., Iacomino, G., Russo, G., (1999) FEBS Lett., 462, pp. 322-328
Scaffidi, C., Schmitz, I., Korsmeyer, S., Krammer, P.H., Peter, M.E., (1999) J. Biol. Chem., 274, pp. 22532-22538
Shao, R.G., Cao, C.X., Pommier, Y., (1997) J. Biol. Chem., 272, pp. 31321-31325
Shimizu, T., Cao, C.X., Shao, R.G., Pommier, Y., (1998) J. Biol. Chem., 273, pp. 8669-8674
Stavric, B., (1994) Clinical Biochem., 27, pp. 319-332
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Loriolle, F., (1991) J. Biol. Chem., 266, pp. 15771-15781
Wajant, H., Haas, E., Schwenzer, R., Muhlenbeck, F., Kreuz, S., Schubert, G., Grell, M., Scheurich, P., (2000) J. Biol. Chem., 275, pp. 24357-24366
Walker, E., Pacold, M., Perisic, O., Stephens, L., Hawkins, P., Wymann, M., Williams, R., (2000) Mol. Cell, 6, pp. 909-919
Wang, I., Lin-Shiau, S., Lin, J., (1999) Eur. J. Cancer, 35, pp. 1517-1525
Weber, G., Shen, F., Yang, H., Prajda, N., Li, W., (1999) Adv. Enzyme Regul., 39, pp. 51-66
Weisburger, J., (2000) Am. J. Clin. Nutr., 71, pp. 1710S-1714S
Yang, C., Landau, J., Huang, M., Newmark, H., (2001) Annu. Rev. Nutr., 21, pp. 381-406
Alderson, M. R., Tough, T. W., Braddy, S., Davis-Smith, T., Roux, E., Schooley, K., Miller, R. E., Lynch, D. H., (1994) Int. Immunol., 6, pp. 1799-1806
Avila, M. A., Velasco, J. A., Cansado, J., Notario, V., (1994) Cancer Res., 54, pp. 2424-2428
Bradford, M. M., (1976) Anal. Biochem., 72, pp. 248-254
(1999) Cancer Res., 59, pp. 4743-4758
Chinnaiyan, A. M., O'Rourke, K., Tewari, M., Dixit, V. M., (1995) Cell, 81, pp. 505-512
Clement, M. V., Stamenkovic, I., (1996) EMBO J., 15, pp. 216-225
Davies, S. P., Reddy, H., Caivano, M., Cohen, P., (2000) Biochem. J., 351, pp. 95-105
Debatin, K. M., Krammer, P., (1995) Leukemia, 9, pp. 815-820
Jarvis, W. D., Turner, A. J., Povirk, L. F., Traylor, R. S., Grant, S., (1994) Cancer Res., 54, pp. 1707-1714
Kang, Z. C., Tsai, S. J., Lee, H., (1999) Nutr. Cancer, 35, pp. 175-179
Krammer, P. H., Galle, P. R., Moller, P., Debatin, K. M., (1998) Advances in Cancer Research, 65, pp. 251-272. , Vande Woude GF and Klein, G. (eds). Academic Press, Inc.: San Diego
Laemmli, U. K., (1970) Nature, 227, pp. 680-685
Larocca, L. M., Ranelletti, F. O., Maggiano, N., Rutella, S., La Barbera, E. O., Rumi, C., Serra, F., Leone, G., (1997) Int. J. Cancer, 73, pp. 75-83
Middleton, E. J., Kandaswami, C., (1993) The Flavonoid: Advance Research Since 1986, pp. 619-652. , Hairbone JH and Liss AR (eds): New York
Reddy, B. S., (2000) Cancer Epidemiol. Biomarkers Prev., 9, pp. 239-247
Rong, Y., Yang, E. B., Zhang, K., Mack, P., (2000) Anticancer Res., 20, pp. 4339-4345
Ruiz-Ruiz, M. C., Robledo, G., Font, J., Izquierdo, M., Lopez-Rivas, A., (1999) J. Immunol., 163, pp. 4737-4746
Shao, R. G., Cao, C. X., Pommier, Y., (1997) J. Biol. Chem., 272, pp. 31321-31325
Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα
We previously demonstrated that quercetin, a naturally occurring flavonoid with strong antioxidant properties, was able to enhance programmed cell death in HPB-acute lymphoblastic leukemia (ALL) cell line, derived from a human tymoma, when associated with the agonistic anti-CD95 monoclonal antibody. Here, we report that HPB-ALL cells are normally resistant to CD95-mediated apoptosis, and quercetin is able to sensitize this cell line through a mechanism independent of its antioxidant properties. In fact, other compounds structurally and functionally similar to quercetin, when associated with anti-CD95 antibody did not induce any CD95-mediated apoptosis, still maintaining their antioxidant capacity. We found that quercetin effects are mediated by the activation of PKCα. Treatment of HPB-ALL cells with quercetin slightly decreased PKCα activity, but when the flavonoid was associated with anti-CD95, the kinase activity increased by 12-fold with respect to the treatment with quercetin. In addition, overexpression of PKCα induced programmed cell death in the absence of any additional stimulus, while a kinase-defective mutant of PKCα was ineffective. Our data confirm the involvement of specific PKC isoforms in CD95 signaling and suggest, for the first time, that quercetin targets this pathway increasing apoptogenic response in a cell line resistant to CD95-mediated apoptosis.
Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα